Rückrich T - Search Results

1

Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells.

Rückrich T, Kraus M, Gogel J, Beck A, Ovaa H, Verdoes M, Overkleeft HS, Kalbacher H, Driessen C. Rückrich T, et al. Leukemia. 2009 Jun;23(6):1098-105. doi: 10.1038/leu.2009.8. Epub 2009 Feb 19. Leukemia. 2009. PMID: 19225532

2

Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.

Kraus M, Malenke E, Gogel J, Müller H, Rückrich T, Overkleeft H, Ovaa H, Koscielniak E, Hartmann JT, Driessen C. Kraus M, et al. Among authors: ruckrich t. Mol Cancer Ther. 2008 Jul;7(7):1940-8. doi: 10.1158/1535-7163.MCT-07-2375. Mol Cancer Ther. 2008. PMID: 18645004

3

Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.

Kraus M, Müller-Ide H, Rückrich T, Bader J, Overkleeft H, Driessen C. Kraus M, et al. Among authors: ruckrich t. Leuk Res. 2014 Mar;38(3):383-92. doi: 10.1016/j.leukres.2013.12.017. Epub 2013 Dec 25. Leuk Res. 2014. PMID: 24418752

4

Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells.

Kraus M, Rückrich T, Reich M, Gogel J, Beck A, Kammer W, Berkers CR, Burg D, Overkleeft H, Ovaa H, Driessen C. Kraus M, et al. Among authors: ruckrich t. Leukemia. 2007 Jan;21(1):84-92. doi: 10.1038/sj.leu.2404414. Epub 2006 Oct 5. Leukemia. 2007. PMID: 17024115

5

Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.

Rückrich T, Brandenburg J, Cansier A, Müller M, Stevanović S, Schilling K, Wiederanders B, Beck A, Melms A, Reich M, Driessen C, Kalbacher H. Rückrich T, et al. Biol Chem. 2006 Oct-Nov;387(10-11):1503-11. doi: 10.1515/BC.2006.188. Biol Chem. 2006. PMID: 17081125

6

Cathepsin S dominates autoantigen processing in human thymic dendritic cells.

Stoeckle C, Quecke P, Rückrich T, Burster T, Reich M, Weber E, Kalbacher H, Driessen C, Melms A, Tolosa E. Stoeckle C, et al. Among authors: ruckrich t. J Autoimmun. 2012 Jun;38(4):332-43. doi: 10.1016/j.jaut.2012.02.003. Epub 2012 Mar 16. J Autoimmun. 2012. PMID: 22424724

7

Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides.

Held SA, Duchardt KM, Tenzer S, Rückrich T, von Schwarzenberg K, Bringmann A, Kurts C, Schild H, Driessen C, Brossart P, Heine A. Held SA, et al. Among authors: ruckrich t. Cancer Immunol Immunother. 2013 Apr;62(4):715-26. doi: 10.1007/s00262-012-1373-7. Epub 2012 Nov 25. Cancer Immunol Immunother. 2013. PMID: 23184338 Free PMC article.

8

Attenuated natural killer (NK) cell activation through C-type lectin-like receptor NKp80 is due to an anomalous hemi-immunoreceptor tyrosine-based activation motif (HemITAM) with impaired Syk kinase recruitment capacity.

Rückrich T, Steinle A. Rückrich T, et al. J Biol Chem. 2013 Jun 14;288(24):17725-33. doi: 10.1074/jbc.M113.453548. Epub 2013 Apr 22. J Biol Chem. 2013. PMID: 23609447 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters